Annovis Bio corrects 2025 audit fees to $415,000 after proxy typo
ANVS•Annovis Bio corrected a typographical error in its proxy for the June 17, 2026, annual meeting. It reported 2025 audit fees of $415,000, audit-related fees of $100,000 and total Ernst & Young fees of $515,000.
1. Corrected fee disclosure
Annovis Bio corrected its audit fee disclosures after a typographical error in its proxy for the June 17, 2026, annual meeting. Ernst & Young’s total fees were $515,000 in 2025 versus $482,045 in 2024; audit fees were $415,000 versus $375,000, and audit-related fees were $100,000 versus $107,045.




